Prognostic indicators for Ebola patient survival

Emerging Infectious Diseases

Volumn 22, Issue 2, 2016, Pages 217-223

  Crowe, Samuel J ^a   Maenner, Matthew J ^a   Kuah, Solomon ^b   Erickson, Bobbie Rae ^a   Coffee, Megan ^b   Knust, Barbara ^a   Klena, John ^a   Foday, Joyce ^c   Hertz, Darren ^b   Hermans, Veerle ^d   Achar, Jay ^e   Caleo, Grazia M ^e   Van Herp, Michel ^d   Albariño, César G ^a   Amman, Brian ^a   Basile, Alison Jane ^a   Bearden, Scott ^a   Belser, Jessica A ^a   Bergeron, Eric ^a   Blau, Dianna ^a   Brault, Aaron C ^a   Campbell, Shelley ^a   Flint, Mike ^a   Gibbons, Aridth ^a   Goodman, Christin ^a   McMullan, Laura ^a   Paddock, Christopher ^a   Russell, Brandy ^a   Salzer, Johanna S ^a   Sanchez, Angela ^a   Sealy, Tara ^a   Wang, David ^a   Saffa, Gbessay ^c   Turay, Alhajie ^c   Nichol, Stuart T ^a   Towner, Jonathan S ^a   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INTERNATIONAL RESCUE COMMITTEE   (United States)

^c MINISTRY OF HEALTH AND SANITATION   (Sierra Leone)

^d MÉDECINS SANS FRONTIÈRES   (Belgium)

^e MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; VIRUS NUCLEOPROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; DEATH; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; EBOLA HEMORRHAGIC FEVER; FEMALE; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HUMAN; ID50; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROGNOSIS; PUBLIC HEALTH SERVICE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; VIRUS LOAD; VIRUS REPLICATION; ADOLESCENT; EBOLAVIRUS; HEALTH SURVEY; HEMORRHAGIC FEVER, EBOLA; HOSPITALIZATION; MIDDLE AGED; MORTALITY; SIERRA LEONE; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; EBOLAVIRUS; FEMALE; HEMORRHAGIC FEVER, EBOLA; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MORTALITY; POPULATION SURVEILLANCE; PROGNOSIS; SIERRA LEONE; YOUNG ADULT;

EID: 84955086192     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2202.151250     Document Type: Article

References (30)

1. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med. 2014;371:1418-25. http://dx.doi.org/10.1056/NEJMoa1404505
2. Fowler RA, Fletcher T, Fischer WA II, Lamontagne F, Jacob S, Brett-Major D, et al. Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med. 2014;190:733-7. http://dx.doi.org/10.1164/rccm.201408-1514CP
3. World Health Organization. Ebola virus disease [cited 2015 Nov 19]. http://www.who.int/mediacentre/factsheets/fs103/en/
4. Centers for Disease Control and Prevention. Ebola (Ebola virus disease): treatment [cited 2015 Nov 19]. http://www.cdc.gov/vhf/ebola/treatment/
5. Qin E, Bi J, Zhao M, Wang Y, Guo T, Yan T, et al. Clinical features of patients with Ebola virus disease in Sierra Leone. Clin Infect Dis. 2015;61:491-5. http://dx.doi.org/10.1093/cid/civ319
6. Fitzpatrick G, Vogt F, Gbabai OB, Decroo T, Keane M, De Clerck H, et al. The contribution of Ebola viral load at admission and other patient characteristics to mortality in a Médecins Sans Frontières (MSF) Ebola Case Management Centre (CMC), Kailahun, Sierra Leone, June-October, 2014. J Infect Dis. 2015;212:1752-8. http://dx.doi.org/10.1093/infdis/jiv304
7. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014;371:2092-100. http://dx.doi.org/10.1056/NEJMoa1411680
8. Sissoko D, Folkesson E, Abdoul M, Beavogui AB, Gunther S, Shepherd S, et al. Favipiravir in patients with Ebola virus disease: early results of the JIKI trial in Guinea. Presented at: Conferenceon Retroviruses and Opportunistic Infections; 2015 Feb 23-26; Seattle, Washington, USA.
9. Medecins Sans Frontieres. Ebola: how does MSF care for patients suffering from Ebola? [cited 2015 Nov 19]. http://www.msf.org/article/ebola-how-does-msf-care-patients-suffering-ebola
10. Centers for Disease Control and Prevention. Ebola virus NP real-time RT-PCR assay [cited 2015 Nov 19]. http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM436307.pdf
11. Centers for Disease Control and Prevention. Ebola virus VP40 real-time RT-PCR assay [cited 2015 Nov 19]. http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM436313.pdf
12. Centers for Disease Control and Prevention. Guidance for collection, transport and submission of specimens for Ebola virus testing [cited 2015 Nov 19]. http://www.cdc.gov/vhf/ebola/healthcare-us/laboratories/specimens.html
13. Leroy EM, Gonzalez JP, Baize S. Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect. 2011;17:964-76. http://dx.doi.org/10.1111/j.1469-0691.2011.03535.x
14. Kortepeter MG, Bausch DG, Bray M. Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis. 2011;204:S810-6. http://dx.doi.org/10.1093/infdis/jir299
15. Feldmann H, Geisbert T. Ebola haemorrhagic fever. Lancet. 2011; 377:849-62. http://dx.doi.org/10.1016/S0140-6736(10)60667-8
16. World Health Organization. Ebola situation report—18 November 2015 [cited 2015 Nov 19]. http://apps.who.int/ebola/current-situation/ebola-situation-report-18-november-2015
17. Ansumana R, Jacobsen KH, Sahr F, Idris M, Bangura H, Boie-Jalloh M, et al. Ebola in Freetown area, Sierra Leone— a case study of 581 patients. N Engl J Med. 2015;372:587-8. http://dx.doi.org/10.1056/NEJMc1413685
18. World Health Organization Ebola Response Team. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med. 2014;371:1481-95. http://dx.doi.org/10.1056/NEJMoa1411100
19. Kucharski AJ, Edmunds WJ. Case fatality rate for Ebola virus disease in west Africa. Lancet. 2014;384:1260. http://dx.doi.org/10.1016/S0140-6736(14)61706-2
20. Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola virus disease in West Africa—clinical manifestations and management. N Engl J Med. 2014;371:2054-7. http://dx.doi.org/10.1056/NEJMp1413084
21. Centers for Disease Control and Prevention. Ebola virus disease (EVD) information for clinicians in U.S. healthcare settings [cited 2015 Nov 19]. http://www.cdc.gov/vhf/ebola/healthcare-us/preparing/clinicians.html
22. West TE, von Saint André-von, Arnim A. Clinical presentation and management of severe Ebola virus disease. Ann Am Thorac Soc. 2014;11:1341-50.
23. Lamontagne F, Clément C, Fletcher T, Jacob ST, Fischer WA II, Fowler RA. Doing today’s work superbly well—treating Ebola with current tools. N Engl J Med. 2014;371:1565-6. http://dx.doi.org/10.1056/NEJMp1411310
24. Frieden TR, Damon I, Bell B, Kenyon T, Nichol S. Ebola 2014—new challenges, new global response and responsibility. N Engl J Med. 2014;371:1177-80. http://dx.doi.org/10.1056/NEJMp1409903
25. Lindblade KA, Kateh F, Nagbe TK, Neatherlin JC, Pillai SK, Attfield KR, et al. Decreased Ebola transmission after rapid response to outbreaks in remote areas, Liberia, 2014. Emerg Infect Dis. 2015;21:1800-7. http://dx.doi.org/10.3201/eid2110.150912
26. Baron RC, McCormick JB, Zubeir OA. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ. 1983;61:997-1003.
27. Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179:S87-91. http://dx.doi.org/10.1086/514284
28. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004;78:4330-41. http://dx.doi.org/10.1128/JVI.78.8.4330-4341.2004
29. McElroy AK, Erickson BR, Flietstra TD, Folkesson E, Abdoul M, Shepherd S, et al. Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis. 2014;210:558-66. http://dx.doi.org/10.1093/infdis/jiu088
30. Rollin PE, Bausch D, Sanchez A. Blood chemistry measurements and d-dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis. 2007; 196:S364-71. http://dx.doi.org/10.1086/520613